Biological Collection of Brain Tumors (GLIOLI)

Biological Collection of Brain Tumors - GLIOLI Collection

The objective of this study is to build a collection of biological samples from patients with brain tumors.

Study Overview

• Status: Recruiting
• Conditions: Brain Tumor
• Intervention / Treatment: Biological: blood and/or csf collection

• Study Type: Observational
• Enrollment (Estimated): 500

Contacts and Locations

• Study Contact: Name: François Ducray, Pr; Phone Number: +33 04 72 68 13 21; Email: francois.ducray@chu-lyon.fr
• Study Contact Backup: Name: Apolline Barthelmé; Phone Number: +33 04 26 73 97 87; Email: Apolline.barthelme@chu-lyon.fr

Study Locations

• France
  • Rhône
    • Bron, Rhône, France, 69500
      • Recruiting
      • Hospices Civils de Lyon
      • Contact: François Ducray, Pr; Phone Number: +33 04 72 68 13 21; Email: francois.ducray@chu-lyon.fr
      • Contact: Appoline Barthelmé; Phone Number: +33 04 26 73 97 87; Email: Apolline.barthelme@chu-lyon.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patient with brain tumor

Description

Inclusion Criteria:

• Patient whose diagnosis of brain tumor has been confirmed.
• Adult patients, from 18 years old and without upper age limit
• Patient affiliated to a social security scheme or equivalent.
• Patient able to consent, having dated and signed an informed consent

Exclusion Criteria:

• Pregnant or breastfeeding women
• Patient under guardianship or curators.
• Persons deprived of their liberty by a judicial or administrative decision

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
brain tumors	Biological: blood and/or csf collection; blood and/or collection Only once : 1 tube of blood of 4 mL on dry tube with or without gel,; 2 tubes of blood of 4 mL on EDTA tube, If CSF collected for diagnosis is available, it can be sent for storage in the collection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of biological samples	number of biological samples	10 years

Collaborators and Investigators

• Sponsor: Hospices Civils de Lyon

Study record dates

Study Major Dates

• Study Start (Actual): November 22, 2023
• Primary Completion (Estimated): November 22, 2033
• Study Completion (Estimated): November 22, 2033

Study Registration Dates

• First Submitted: October 3, 2022
• First Submitted That Met QC Criteria: October 5, 2022
• First Posted (Actual): October 7, 2022

Study Record Updates

• Last Update Posted (Actual): January 20, 2026
• Last Update Submitted That Met QC Criteria: January 16, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Keywords: Brain tumor
• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neoplasms by Site; Neoplasms; Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms
• Other Study ID Numbers: 69HCL22_0813

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No